Product
SG301 SC
Aliases
SG301 SC Placebo
1 clinical trial
1 indication
Indication
Systemic Lupus Erythematosus (SLE)Clinical trial
A Randomized, Double-blind, Placebo-controlled Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Characteristics of SG301 SC Injection in Single-dose Healthy Subjects and Multiple-dose Systemic Lupus Erythematosus (SLE) SubjectsStatus: Recruiting, Estimated PCD: 2025-05-19